Myeloma Minute: Latest Cancer Research Viewed Through a Myeloma Lens


| INNOVATION | Dr. Durie's Blog


In the News: Early Diagnosis, CRISPR Gene-Editing, and CAR T-Cell Therapies

What does the new cancer research mean for patients? IMF Chairman Dr. Brian G.M. Durie sees a fresh take on MGUS, the curative potential of cloning, and questions on the value of early diagnosis.


| MEDICAL | Staff Update

Joseph Mikhael.jpg


| ACTION | Fundraiser


Dr. Joseph Mikhael Joins the IMF
A Journey Into the Five Senses

World-renowned myeloma expert Dr. Joseph Mikhael has joined the IMF as Chief Medical Officer. Dr. Mikhael will be working closely with Dr. Brian Durie, the IMF's Chair of the Board, to advance the mission of the organization and improve lives of patients with multiple myeloma.


Accomplished artist Claudia Meyer hosts her solo art show “Sensoria” at the Castelli Art Space at 5440 W. Washington Blvd. in Los Angeles from February 3-11, 2018. A portion of all sales of her works from this event will benefit the IMF.




| INNOVATION | Latest Research 


FDA Adds Overall Survival Data to Kyprolis Label

The Food and Drug Administration (FDA) approved adding “overall survival data from the phase III head-to-head ENDEAVOR trial to the Prescribing Information for Kyprolis® (carfilzomib).” Learn more from this press release and about the ENDEAVOR trial.  



FDA Gives Priority Review to Daratumumab in Frontline Myeloma

The Food and Drug Administration (FDA) grants “Priority Review to the supplemental Biologics License Application (sBLA) for the use of Darzalex® (daratumumab) in combination with bortezomib, melphalan, and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT).”


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



BOSTON Trial Fact Sheet

New selinexor STORM Trial: Learn How to Participate

New ARROW Clinical Trials: Learn How to Participate

New ixazomib Clinical Trials: Learn How to Participate

Join the conversation about myeloma on the Smart Patients Message Board


Listen to a Replay: Best of ASH 2017 teleconference

February 3, 2018
IMF Regional Community Workshop
Raleigh, NC

February 25, 2018
IMF Patient & Family Seminar
San Francisco, CA

February 25, 2018
Multiple Myeloma Symposium
Kingston, Jamaica

March 10, 2018
IMF Regional Community Workshop
Denver, CO

March 16-17, 2018
IMF Patient & Family Seminar
Boca Raton, FL

April 21, 2018
IMF Regional Community Workshop
Nashville, TN


subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology
and individuals like you who supported the IMF this year

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.